RXRX - Latest News

Recursion Pharmaceuticals, Inc. (RXRX), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $1.66B. Beta to the broader market is 1.03.

The article list below shows the most recent RXRX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent RXRX Headlines

Recursion Pharmaceuticals, Inc. $RXRX Stake Increased by California State Teachers Retirement System

defenseworld.net - Aug 13, 2026

California State Teachers Retirement System lifted its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) by 64.

Recursion Pharmaceuticals, Inc. (RXRX) Presents at Bank of America SMID Cap Virtual Conference Transcript

seekingalpha.com - Aug 11, 2026

Recursion Pharmaceuticals, Inc.

The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech)

247wallst.com - Aug 11, 2026

Anthropic is preparing what could be the largest IPO of 2026, and it's telling investors the pitch goes well beyond chatbots. According to the Wall S

Recursion Pharmaceuticals: I'm Still Bearish Despite Recent Genentech News

seekingalpha.com - Aug 10, 2026

Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions.

RXRX Q2 Earnings Miss Estimates, Revenues Fall Y/Y, Stock Down

zacks.com - Aug 6, 2026

Recursion misses Q2 earnings and revenue estimates as collaboration revenues fall year over year, sending shares lower while pipeline and partnership

How News Affects RXRX Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RXRX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked RXRX news questions

What is the latest RXRX news headline?

The most recent RXRX headline (Aug 13, 2026) is "Recursion Pharmaceuticals, Inc. $RXRX Stake Increased by California State Teachers Retirement System". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the RXRX news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What RXRX news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual RXRX options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.